Overview
Jialiang Lu practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Angioimmunoblastic T-cell Lymphoma, Lymphofollicular Hyperplasia, Non-Hodgkin Lymphoma, and Gallbladder Removal.
They are actively involved in clinical research, co-authoring 24 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jialiang Lu
Is Jialiang Lu a top-rated expert for Angioimmunoblastic T-cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jialiang Lu is classified as an Experienced expert for Angioimmunoblastic T-cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jialiang Lu participate in research or clinical trials?
Yes. Jialiang Lu has published 24 articles and abstracts on conditions like Angioimmunoblastic T-cell Lymphoma. You can view a list of Jialiang Lu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Angioimmunoblastic T-cell Lymphoma
- Gallbladder RemovalLu isExperienced. Learn about Gallbladder Removal.
- Lymphofollicular Hyperplasia
- Non-Hodgkin LymphomaLu isExperienced. Learn about Non-Hodgkin Lymphoma.